Market Overview

UPDATE: Jefferies Raises PT to $65 on CME Group on Long-Term Outlook

Related CME
UPDATE: GFI Issues Response to Unsolicited Bid from BGC, Sees Offer as Reasonably Leading to Superior Proposal, Continues to support Deal with CME
UPDATE: Deutsche Bank Initiates Coverage On 4 U.S. Securities Exchanges
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

Jefferies reiterated its Buy rating on CME Group (NASDAQ: CME) and raised its price target from $60 to $65.

Jefferies noted, "Last week we spent several days with the management team of CME Group. The focus of the meetings centered around OTC clearing and execution initiatives and the globalization of CME's products, all of which represent potential offsets to the current lackluster environment for trading. On a longer-term basis we see several structural changes that should drive accelerating growth at CME."

CME Group closed at $57.29 on Friday.

Latest Ratings for CME

DateFirmActionFromTo
Sep 2014Deutsche Bank
Sep 2014Deutsche BankInitiates Coverage onBuy
Aug 2014BarclaysMaintainsEqual-weight

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters